Compare Figma Inc. Class A Common Stock (FIG) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figma Inc. Class A Common Stock vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? Figma Inc. Class A Common Stock trades at $21.26 (market cap $11.60B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B). The key difference: Figma Inc. Class A Common Stock is the larger of the two by market cap, and Figma Inc. Class A Common Stock is more actively traded (12,281,013 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Figma Inc. Class A Common Stock for 0 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| FIG | IONS | |
|---|---|---|
Market Cap | $11.60B | $7.04B |
Volume | 12,281,013 | 2,977,440 |
Sector | Technology | Health |
52-Week High | $63.82 | $86.50 |
52-Week Low | $16.84 | $42.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.00B | $6.60B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Figma Inc. Class A Common Stock
Figma, Inc. is a US software company that operates a collaborative interface design and product development platform used by design and engineering teams to create, prototype, and build digital products.
Read more on FIG →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
